（来源：廊坊日报） 转自：廊坊日报 本报讯（记者 郑爽 通讯员 任蕊）日前，家住安次区豪邸坊小区的居民刘女士，带着刚满13岁的女儿免 费接种HPV疫苗，"孩子一放寒假就带她来打了，整个过程高效方便。" 为保障儿童青少年健康成长，根据国家疾控局等七部门印发的《关于将人乳头瘤病毒疫苗纳入国家免疫 规划有关工作事宜的通知》要求，自2025年11月10日起，全国范围内为2011年11月10日以后出生的满13 周岁女孩，免费接种2剂次双价HPV疫苗。 世界卫生组织（WHO）推荐，9~14岁女孩是HPV疫苗接种的首要人群。HPV主要通过性行为感染，在 感染风险显著增加之前（即发生性行为年龄之前）接种，能获得最佳的保护效果，实现"早接种，早保 护"。同时大量数据表明，这个年龄段接种能够获得最佳的预防效果，是最及时、最经济、最有效的保 护措施。基于充分的科学论证和国际经验，我国确定了该防护策略。 接种对象：2011年11月10日以后出生年满13周岁的女孩。 接种程序：接种2剂次双价HPV疫苗，间隔6个月。已完成其他HPV疫苗（包括双价、四价或九价）全程 接种的孩子无需重复接种。 工作人员表示，我市除免疫规划双价HPV疫苗免费 ...

Group 1 - The Shanghai Women's Federation announced proposals focusing on women's employment, dual pressures of childbirth, and HPV vaccination during a press conference [1] - The HPV vaccine was included in the national immunization program on October 10, 2022, with free vaccinations for eligible girls starting November 10, 2022. However, there is a mismatch between supply and diverse demand, leading to structural contradictions of "high demand, high price, low accessibility" [3] - The Federation suggested enhancing the price adjustment mechanism for collective procurement and adopting a "universal + tiered subsidy" model to optimize service supply for HPV vaccinations [3] Group 2 - The city has initiated a "family-friendly job" pilot program to support women in balancing family and career, addressing employment barriers caused by childcare. Initial results have been observed, but issues remain regarding job quality, career pathways, and service precision [5] - The Federation recommended forming regional alliances to encourage more companies to offer flexible and remote work positions, alongside studying comprehensive tax incentives for businesses establishing formal "family-friendly jobs" [5] - The Federation's Development Liaison Department indicated that there is a strong possibility of implementing incentives for registered family-friendly enterprises, aiming to facilitate a better work-life balance for young parents [7]

Core Insights - The article highlights the ongoing efforts in Jiangsu Province to provide free HPV vaccinations to eligible schoolgirls as part of a public health initiative aimed at preventing cervical cancer [1][2][4] Group 1: Vaccination Program Overview - The HPV vaccination program has been included in the provincial government's livelihood projects for three consecutive years, with 197,000 first-year female students vaccinated in the first ten months of this year, totaling 843,800 over three years [1] - The vaccination is part of the "Jiangsu Province Action Plan for Accelerating the Elimination of Cervical Cancer (2023-2030)," which emphasizes HPV vaccination as a primary preventive measure [1][2] Group 2: Implementation and Accessibility - Various cities in Jiangsu have established comprehensive vaccination networks, with Nantong City planning to vaccinate over 11,500 first-year girls by 2025, and Lianyungang City aiming for 16,400 [2] - Wuxi has been a pioneer in this initiative, having started the free vaccination program in December 2021, with nearly 130,000 doses administered to about 70,000 girls [2] Group 3: Community Engagement and Education - Local health departments have implemented measures to facilitate vaccination, such as weekend vaccination sessions and online appointment systems, addressing concerns about accessibility for working parents [3] - Educational outreach has included over 1,100 promotional events, reaching more than 200,000 people, and distributing over 360,000 informational letters to parents [4] Group 4: Economic Impact of Vaccination - Research indicates that without vaccination, approximately 1% of women born in China between 2005 and 2014 would develop cervical cancer, with lifetime treatment costs estimated at 140,000 yuan per patient [4] - The vaccination program is projected to prevent 9,500 cases of cervical cancer over three years, saving families and society approximately 1.33 billion yuan in treatment costs [4] Group 5: Future Directions - The provincial health commission plans to continue strengthening vaccination efforts and integrate HPV vaccination with cervical cancer screening, enhancing the maternal and child health service system [5]

Core Viewpoint - The article highlights the launch of a "one shot, one free" HPV vaccination initiative in Zhuhai, aimed at increasing vaccination rates among eligible populations, particularly young girls and boys, by providing financial incentives and simplifying the vaccination process [1][2]. Group 1: Vaccination Initiative Details - The initiative includes a dual-track model combining national free basic coverage with local enhanced options, allowing eligible citizens to receive the second or third dose of the HPV vaccine for free [1][2]. - The program targets girls aged 9-14, who can receive the second dose of the imported nine-valent HPV vaccine for free, while males aged 16-26 and females aged 15-26 and 35-45 can receive the third dose for free [2][3]. - Eligible individuals must receive their first dose between December 1, 2025, and September 30, 2026, and complete the vaccination by March 31, 2027, to benefit from the discounts [2]. Group 2: Community Engagement and Accessibility - The Zhuhai health authorities are actively engaging with schools and communities to promote the vaccination program, ensuring that parents are informed and can easily access vaccination services [3][4]. - The vaccination centers are offering one-stop services, including consultation, registration, and vaccination, to streamline the process for families [4][5]. - Special weekend vaccination sessions are being organized to accommodate families' schedules, allowing parents to utilize their weekends for vaccinations without disrupting their children's school activities [4][6]. Group 3: Public Awareness and Education - Health officials emphasize the importance of vaccinating girls aged 9-14, as this age group has the best immune response, requiring only two doses for effective protection [6]. - The community is addressing common concerns among parents regarding the vaccine's impact on menstrual cycles, reassuring them that the HPV vaccine does not affect hormonal systems [5][6]. - The vaccination initiative is designed not only as a health measure but also as a well-planned educational opportunity for families, integrating health into the school calendar [4].

Core Viewpoint - The launch of the cervical cancer comprehensive prevention project in low-resource areas of China aims to enhance health equity and combat cervical cancer through HPV vaccination, supported by Merck and the China Cancer Foundation [1][3][5] Group 1: Project Launch and Support - The cervical cancer prevention project was officially launched in Aohan Banner, Chifeng City, Inner Mongolia, with attendance from key officials and representatives from the China Cancer Foundation and Merck [1] - Merck has donated a total of 81,000 doses of HPV vaccine to the China Cancer Foundation, which will be distributed for free vaccination of eligible middle school girls in several provinces [1] Group 2: Health Challenges and Statistics - HPV infection is a significant health threat to women in China, with cervical cancer being the fourth most common cancer among women globally, and China reporting the highest incidence and second-highest mortality rates in 2022 [3] - The incidence of cervical cancer in China has been rising, particularly among younger women, highlighting the urgency of addressing this public health issue [3] Group 3: Strategic Response and Guidelines - In response to the WHO's global strategy to accelerate the elimination of cervical cancer, China has launched the "Accelerated Action Plan for Cervical Cancer Elimination (2023-2030)" [3] - The 2023 guidelines emphasize the importance of health education and HPV vaccination as effective preventive measures against HPV-related diseases, although vaccination rates remain low in some under-resourced areas [3]

Group 1 - The core point of the article is that the HPV vaccine has been included in the national immunization program in China, with the domestically developed nine-valent HPV vaccine officially in use [1] - The National Health Commission announced that HPV vaccination services will be provided for eligible girls this year, enhancing the accessibility and affordability of HPV vaccines in China [1] - The nine-valent HPV vaccine developed by Wantai Biological Pharmacy has been approved for market launch, making it the first domestically produced nine-valent HPV vaccine in China and the second globally [1] Group 2 - The price of the domestically produced nine-valent HPV vaccine is set at 499 yuan per dose, which is approximately 40% of the price of imported similar products [2] - For females aged 9 to 17, a two-dose vaccination schedule costs a total of 998 yuan, while for those aged 18 to 45, a three-dose schedule costs about 1500 yuan [2]

Group 1 - Guangzhou has initiated HPV vaccination programs across multiple districts, including Panyu, Tianhe, Yuexiu, Haizhu, Zengcheng, Huadu, and Baiyun, with no restrictions on residency or household registration [1] - The vaccination campaign aims to establish a comprehensive prevention system covering adolescents, adult women, and men, encouraging early vaccination for better protection against cervical cancer [1] - Experts emphasize the importance of HPV vaccination for both genders, as HPV infection poses health risks to men and women alike, and early vaccination can help prevent the spread of the virus [2][3] Group 2 - The majority of cervical cancer cases are linked to persistent high-risk HPV infections, with recommendations for girls aged 9 to 14 being the primary target group for vaccination [2] - There is a growing trend of HPV infections among younger populations, highlighting the need for early vaccination to maximize benefits [2] - The nine-valent HPV vaccine has been used in 112 countries, accumulating extensive real-world data, allowing individuals to choose from different types of HPV vaccines based on their health needs [3]

Core Points - The Guangxi Health Commission, along with other departments, has launched a free HPV vaccination program for eligible girls in Guangxi, aiming to vaccinate nearly 960,000 girls from 2025 to 2027 [1] - The program targets middle school girls aged 13 to under 14 who have not previously received the HPV vaccine, ensuring a comprehensive vaccination coverage across urban and rural areas [1][2] - The vaccination information will be integrated into the immunization planning information system to ensure traceability and control over the vaccination process [1] Group 1 - The HPV vaccine is crucial in preventing cervical and anal cancers, with the best protection achieved when administered before the onset of sexual activity [2] - Since 2021, the Guangxi Women's Federation has raised 7.8 million yuan to support the "Accelerate the Elimination of Cervical Cancer Action Plan," providing free vaccinations to 7,483 women [2] - The free vaccination policy has been expanded to cover all eligible girls in both urban and rural areas, with significant support from local representatives [2]

Core Points - The article discusses the launch of a free HPV vaccination program for eligible girls in Hangzhou, Zhejiang Province, as part of a key public health initiative for 2025 [1] - HPV is a common virus that can lead to serious health issues, including cervical cancer, with 90% of cervical cancer cases linked to HPV infection [1] - The program targets girls aged 13-14, aligning with WHO recommendations for optimal vaccination timing [1][2] Group 1: Vaccination Program Details - The vaccination is specifically for girls with Zhejiang Province residency or school enrollment [2] - Eligible girls must be aged 13-14 and should not have any prior HPV vaccinations [2] - The program offers the domestic bivalent HPV vaccine, with a recommended two-dose schedule [3] Group 2: Vaccination Guidelines - The vaccination schedule suggests administering doses at 0 and 6 months, with a minimum interval of 5 months [3] - Certain health conditions, such as fever or acute diseases, may require postponement of vaccination [3] - Parents and guardians are encouraged to consult local health authorities for specific vaccination information [3]

Group 1 - The core viewpoint of the article highlights the launch of the free vaccination program for the bivalent HPV vaccine for girls aged 13-14 in Hangzhou, which has been part of the municipal government's livelihood projects for two consecutive years [1][2] - Since the program's initiation in 2024, over 10,000 eligible girls have been vaccinated, with more than 600 girls in the Qingshan District having received their first dose [1] - The vaccination aims to build a health defense against HPV, which is linked to various cancers, particularly cervical cancer, with 90% of cases caused by HPV infection [1] Group 2 - The World Health Organization recommends girls aged 9-14 as the primary target group for HPV vaccination due to their ability to develop higher immunity at a younger age [2] - The vaccination program is open to girls with Zhejiang province residency or school enrollment, who have not previously received the HPV vaccine, and consists of two doses administered at least five months apart [2] - Precautions are advised for those with fever, acute diseases, or chronic disease flare-ups, who should postpone or avoid vaccination [2]